Riken Vitamin Co., Ltd.'s market cap is currently ¥60.12B. The company's EPS TTM is ¥275.77; its P/E ratio is 8.45; and it has a dividend yield of 3.91%. Riken Vitamin Co., Ltd. is scheduled to report earnings on February 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	¥ 91.48B	¥ 88.75B	¥ 79.23B	¥ 77.72B	¥ 82.97B
Gross Profit	¥ 29.89B	¥ 27.24B	¥ 25.57B	¥ 22.01B	¥ 27.46B
Operating Income	¥ 9.37B	¥ 7.16B	¥ 5.84B	¥ 1.37B	¥ 6.39B
EBITDA	¥ 15.35B	¥ 10.85B	¥ 9.58B	¥ 5.32B	¥ -2.18B
Net Income	¥ 8.76B	¥ 6.41B	¥ 21.58B	¥ -1.62B	¥ -7.85B
Balance Sheet
Cash & Short-Term Investments	¥ 23.38B	¥ 19.16B	¥ 17.30B	¥ 19.23B	¥ 14.54B
Total Assets	¥ 118.78B	¥ 105.22B	¥ 102.66B	¥ 106.53B	¥ 104.45B
Total Debt	¥ 16.05B	¥ 14.56B	¥ 17.53B	¥ 24.37B	¥ 23.15B
Net Debt	¥ -7.33B	¥ -4.59B	¥ 232.00M	¥ 5.14B	¥ 8.61B
Total Liabilities	¥ 42.13B	¥ 33.85B	¥ 36.12B	¥ 59.86B	¥ 55.08B
Stockholders' Equity	¥ 76.61B	¥ 71.34B	¥ 66.52B	¥ 46.16B	¥ 48.88B
Cash Flow
Free Cash Flow	¥ 7.42B	¥ 5.67B	¥ 3.44B	¥ 3.85B	¥ 464.00M
Operating Cash Flow	¥ 10.45B	¥ 7.83B	¥ 6.82B	¥ 7.63B	¥ 5.85B
Investing Cash Flow	¥ -554.00M	¥ -2.03B	¥ -3.66B	¥ -2.29B	¥ -4.28B
Financing Cash Flow	¥ -7.08B	¥ -4.58B	¥ -7.57B	¥ -180.00M	¥ -3.05B

Currency in JPY

Riken Vitamin Co., Ltd. Earnings and Revenue History

Income Statement >

Riken Vitamin Co., Ltd. Debt to Assets

Balance Sheet >

Riken Vitamin Co., Ltd. Cash Flow

Cash Flow >

Riken Vitamin Co., Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing